Development of Epstein-Barr virus vaccines:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York u.a.
Springer u.a.
1995
|
| Schriftenreihe: | Medical intelligence unit
|
| Schlagworte: | |
| Beschreibung: | 126 S. Ill., graph. Darst. |
| ISBN: | 3540588868 1570591121 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010153216 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 950426s1995 ad|| |||| 00||| eng d | ||
| 016 | 7 | |a 94429684X |2 DE-101 | |
| 020 | |a 3540588868 |9 3-540-58886-8 | ||
| 020 | |a 1570591121 |9 1-57059-112-1 | ||
| 035 | |a (OCoLC)32971169 | ||
| 035 | |a (DE-599)BVBBV010153216 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 050 | 0 | |a QR201.E75 | |
| 082 | 0 | |a 616/.0194 |2 20 | |
| 084 | |a XD 7350 |0 (DE-625)152594:13129 |2 rvk | ||
| 100 | 1 | |a Morgan, Andrew J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Development of Epstein-Barr virus vaccines |c Andrew J. Morgan |
| 264 | 1 | |a New York u.a. |b Springer u.a. |c 1995 | |
| 300 | |a 126 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Medical intelligence unit | |
| 650 | 7 | |a Epstein-Barr-virus |2 gtt | |
| 650 | 2 | |a Human herpesvirus 4 | |
| 650 | 2 | |a Vaccins antiviraux | |
| 650 | 7 | |a Vaccins |2 gtt | |
| 650 | 7 | |a Virusziekten |2 gtt | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Epstein-Barr virus diseases | |
| 650 | 4 | |a Herpesviridae Infections |x prevention & control | |
| 650 | 4 | |a Herpesvirus 4, Human | |
| 650 | 4 | |a Vaccines | |
| 650 | 4 | |a Viral vaccines | |
| 650 | 0 | 7 | |a Epstein-Barr-Virus |0 (DE-588)4152573-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Epstein-Barr-Virus-Infektion |0 (DE-588)4265095-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Epstein-Barr-Virus-Infektion |0 (DE-588)4265095-1 |D s |
| 689 | 0 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Epstein-Barr-Virus |0 (DE-588)4152573-5 |D s |
| 689 | 1 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006744567 | ||
Datensatz im Suchindex
| _version_ | 1804124549836439552 |
|---|---|
| any_adam_object | |
| author | Morgan, Andrew J. |
| author_facet | Morgan, Andrew J. |
| author_role | aut |
| author_sort | Morgan, Andrew J. |
| author_variant | a j m aj ajm |
| building | Verbundindex |
| bvnumber | BV010153216 |
| callnumber-first | Q - Science |
| callnumber-label | QR201 |
| callnumber-raw | QR201.E75 |
| callnumber-search | QR201.E75 |
| callnumber-sort | QR 3201 E75 |
| callnumber-subject | QR - Microbiology |
| classification_rvk | XD 7350 |
| ctrlnum | (OCoLC)32971169 (DE-599)BVBBV010153216 |
| dewey-full | 616/.0194 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616/.0194 |
| dewey-search | 616/.0194 |
| dewey-sort | 3616 3194 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01824nam a2200565 c 4500</leader><controlfield tag="001">BV010153216</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">950426s1995 ad|| |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">94429684X</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540588868</subfield><subfield code="9">3-540-58886-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1570591121</subfield><subfield code="9">1-57059-112-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)32971169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010153216</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR201.E75</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616/.0194</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 7350</subfield><subfield code="0">(DE-625)152594:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Morgan, Andrew J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development of Epstein-Barr virus vaccines</subfield><subfield code="c">Andrew J. Morgan</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York u.a.</subfield><subfield code="b">Springer u.a.</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">126 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Medical intelligence unit</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epstein-Barr-virus</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Human herpesvirus 4</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Vaccins antiviraux</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccins</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Virusziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epstein-Barr virus diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herpesviridae Infections</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herpesvirus 4, Human</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Viral vaccines</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Epstein-Barr-Virus</subfield><subfield code="0">(DE-588)4152573-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Epstein-Barr-Virus-Infektion</subfield><subfield code="0">(DE-588)4265095-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Epstein-Barr-Virus-Infektion</subfield><subfield code="0">(DE-588)4265095-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Epstein-Barr-Virus</subfield><subfield code="0">(DE-588)4152573-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006744567</subfield></datafield></record></collection> |
| id | DE-604.BV010153216 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:47:26Z |
| institution | BVB |
| isbn | 3540588868 1570591121 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006744567 |
| oclc_num | 32971169 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 126 S. Ill., graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Springer u.a. |
| record_format | marc |
| series2 | Medical intelligence unit |
| spelling | Morgan, Andrew J. Verfasser aut Development of Epstein-Barr virus vaccines Andrew J. Morgan New York u.a. Springer u.a. 1995 126 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Medical intelligence unit Epstein-Barr-virus gtt Human herpesvirus 4 Vaccins antiviraux Vaccins gtt Virusziekten gtt Drug Design Epstein-Barr virus diseases Herpesviridae Infections prevention & control Herpesvirus 4, Human Vaccines Viral vaccines Epstein-Barr-Virus (DE-588)4152573-5 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf Epstein-Barr-Virus-Infektion (DE-588)4265095-1 gnd rswk-swf Epstein-Barr-Virus-Infektion (DE-588)4265095-1 s Impfstoff (DE-588)4026655-2 s DE-604 Epstein-Barr-Virus (DE-588)4152573-5 s |
| spellingShingle | Morgan, Andrew J. Development of Epstein-Barr virus vaccines Epstein-Barr-virus gtt Human herpesvirus 4 Vaccins antiviraux Vaccins gtt Virusziekten gtt Drug Design Epstein-Barr virus diseases Herpesviridae Infections prevention & control Herpesvirus 4, Human Vaccines Viral vaccines Epstein-Barr-Virus (DE-588)4152573-5 gnd Impfstoff (DE-588)4026655-2 gnd Epstein-Barr-Virus-Infektion (DE-588)4265095-1 gnd |
| subject_GND | (DE-588)4152573-5 (DE-588)4026655-2 (DE-588)4265095-1 |
| title | Development of Epstein-Barr virus vaccines |
| title_auth | Development of Epstein-Barr virus vaccines |
| title_exact_search | Development of Epstein-Barr virus vaccines |
| title_full | Development of Epstein-Barr virus vaccines Andrew J. Morgan |
| title_fullStr | Development of Epstein-Barr virus vaccines Andrew J. Morgan |
| title_full_unstemmed | Development of Epstein-Barr virus vaccines Andrew J. Morgan |
| title_short | Development of Epstein-Barr virus vaccines |
| title_sort | development of epstein barr virus vaccines |
| topic | Epstein-Barr-virus gtt Human herpesvirus 4 Vaccins antiviraux Vaccins gtt Virusziekten gtt Drug Design Epstein-Barr virus diseases Herpesviridae Infections prevention & control Herpesvirus 4, Human Vaccines Viral vaccines Epstein-Barr-Virus (DE-588)4152573-5 gnd Impfstoff (DE-588)4026655-2 gnd Epstein-Barr-Virus-Infektion (DE-588)4265095-1 gnd |
| topic_facet | Epstein-Barr-virus Human herpesvirus 4 Vaccins antiviraux Vaccins Virusziekten Drug Design Epstein-Barr virus diseases Herpesviridae Infections prevention & control Herpesvirus 4, Human Vaccines Viral vaccines Epstein-Barr-Virus Impfstoff Epstein-Barr-Virus-Infektion |
| work_keys_str_mv | AT morganandrewj developmentofepsteinbarrvirusvaccines |